Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: Efficacy and safety in actual clinical practice

Journal of Clinical Neuroscience

Volumn 12, Issue 8, 2005, Pages 891-894

  Ono, Ayumu ^a   Fujita, Toshiro ^b  

^a Otsuki Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atrial fibrillation; Complications; Elderly patients; Low intensity anticoagulation; Stroke

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLADDER CANCER; CLINICAL PRACTICE; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FEMALE; HEMORRHAGE; HUMANS; MALE; PRIMARY HEALTH CARE; PROTHROMBIN TIME; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 28544443789     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.10.011     Document Type: Article

References (32)

1. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
2. M. Sudlow, R. Thomson, B. Thwaites, H. Rodgers, and R.A. Kenny Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167 1171
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study Arch Intern Med 147 1987 1561 1564
4. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
5. S.M. Hardman, and M.R. Cowie Fortnightly review: anticoagulation in heart disease BMJ 318 1999 238 244
6. A. Evans, and L. Kalra Are the Results of Randomized Controlled Trials on Anticoagulation in Patients With Atrial Fibrillation Generalizable to Clinical Practice? Arch-Intern-Med 161 2001 1443 1447
7. R.J. Beyth, L.M. Quinn, and C.S. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99
8. J. Whittle, L. Wickenheiser, and L.N. Venditti Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 157 1997 441 445
9. G.C. Flaker, D.J. McGowan, M. Boechler, G. Fortune, and B. Gage Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation Am Heart J 137 1999 307 312
10. D.C. McCrory, D.B. Matchar, G. Samsa, L.L. Sanders, and E.L. Pritchett Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly Arch Intern Med 155 1995 277 281
11. A. Ono Rapid anticoagulation testing is not available in general practitioners' clinics in Japan BMJ 321 2000 1157
12. G.Y. Lip Thromboprophylaxis for atrial fibrillation Lancet 353 1999 4 6
13. G.W. Albers, J.E. Dalen, A. Laupacis, W.J. Manning, P. Petersen, and D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 119 2001 194S 206S
14. V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary Circulation 104 2001 2118 2150
15. R.G. Hart, D.G. Sherman, J.D. Easton, and J.A. Cairns Prevention of stroke in patients with nonvalvular atrial fibrillation Neurology 51 1998 674 681
16. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
17. M.D. Ezekowitz, S.L. Bridgers, and K.E. James Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators N Engl J Med 327 1992 1406 1412
18. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348: 633-638.
19. Yamaguchi T for Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial. Stroke 2000;31:817-821.
20. V. Pengo, F. Barbero, A. Biasiolo, C. Pegoraro, F. Noventa, and S. Iliceto Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment Thromb Haemost 89 2003 760 764
21. The Joint Committee on Guidelines for the Management of Stroke. Japanese Guidelines for the Management of Stroke. Tokyo, Kyowa Kikaku, 2004 (in Japanese).
22. H.P. Adams, B.H. Bendixen, and L.J. Kappelle Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
23. M.N. Levine, G. Raskob, S. Landefeld, and J. Hirsh Hemorrhagic complications of anticoagulant treatment Chest 108 1995 276S 290S
24. H. Sahai, and A. Khurshid Statistics in epidemiology. Methods, techniques, and applications 1996 CRC press New York
25. A. Howitt, and D. Armstrong Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation BMJ 318 1999 1324 1327
26. T.R. Lancaster, D.E. Singer, and M.A. Sheehan The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators Arch Intern Med 151 1991 1944 1949
27. A.L. Gullov, B.G. Koefoed, and P. Petersen Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation Arch Intern Med 159 1999 1322 1328
28. A.D. Blann, D.A. Fitzmaurice, and G.Y. Lip Anticoagulation in hospitals and general practice BMJ 326 2003 153 156
29. E. Chiquette, M.G. Amato, and H.I. Bussey Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs Arch Intern Med 158 1998 1641 1647
30. E.M. Hylek, S.J. Skates, M.A. Sheehan, and D.E. Singer An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 335 1996 540 546
31. E.M. Hylek, A.S. Go, and Y. Chang Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019 1026
32. G.W. Albers Atrial fibrillation and stroke. Three new studies, three remaining questions Arch Intern Med 154 1994 1443 1448